Peroxisome proliferator-activated receptor-gamma: potential molecular therapeutic target for HIV-1-associated brain inflammation
Abstract Background Despite the use of combination antiretroviral therapy for the treatment of HIV-1 infection, cognitive impairments remain prevalent due to persistent viral replication and associated brain inflammation. Primary cellular targets of HIV-1 in the brain are macrophages, microglia, and...
Main Authors: | Amila Omeragic, Md Tozammel Hoque, U-yeong Choi, Reina Bendayan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-09-01
|
Series: | Journal of Neuroinflammation |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12974-017-0957-8 |
Similar Items
-
Defining C3-V4 neutralisation epitopes on human immunodeficiency virus type-1 subtype c envelope glycoproteins
by: Wibmer, Constantinos Kurt
Published: (2012) -
The Immunotherapeutic Effects of Pentoxifylline in Type 1 Diabetic Mice and its Effects on Expressions of Peroxisome proliferator-activated receptor gamma (PPARγ) gene
by: F Malekifar, et al.
Published: (2015-05-01) -
The expression, purification and characterisation of recombinant HIV-1 subtype C gp120
by: Michler, Katherine Laura
Published: (2008) -
HIV-1 Envelope Protein gp120 Promotes Proliferation and the Activation of Glycolysis in Glioma Cell
by: Gabriel Valentín-Guillama, et al.
Published: (2018-09-01) -
Exploration des contraintes génétiques et structurelles à la génération de formes du VIH-1 portant des enveloppes recombinantes
by: Hamoudi, Meriem
Published: (2012)